These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20143328)

  • 21. A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia.
    Topp L; Day CA; Wand H; Deacon RM; van Beek I; Haber PS; Shanahan M; Rodgers C; Maher L;
    Prev Med; 2013 Oct; 57(4):297-303. PubMed ID: 23639625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis.
    Kramer ES; Hofmann C; Smith PG; Shiffman ML; Sterling RK
    Dig Dis Sci; 2009 Sep; 54(9):2016-25. PubMed ID: 19517231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.
    Collier MG; Drobeniuc J; Cuevas-Mota J; Garfein RS; Kamili S; Teshale EH
    Vaccine; 2015 Jun; 33(24):2808-12. PubMed ID: 25889161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis A/B vaccine completion among homeless adults with history of incarceration.
    Nyamathi AM; Marlow E; Branson C; Marfisee M; Nandy K
    J Forensic Nurs; 2012 Mar; 8(1):13-22. PubMed ID: 22372394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users.
    Seal KH; Kral AH; Lorvick J; McNees A; Gee L; Edlin BR
    Drug Alcohol Depend; 2003 Aug; 71(2):127-31. PubMed ID: 12927650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.
    Jakiche R; Borrego ME; Raisch DW; Gupchup GV; Pai MA; Jakiche A
    Am J Med Sci; 2007 Jan; 333(1):26-34. PubMed ID: 17220691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
    Kramer JR; Hachem CY; Kanwal F; Mei M; El-Serag HB
    Hepatology; 2011 Jan; 53(1):42-52. PubMed ID: 21254161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
    de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?
    Hernandez B; Hasson NK; Cheung R
    Am J Gastroenterol; 2009 Aug; 104(8):1961-7. PubMed ID: 19491840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two Web-Based and Theory-Based Interventions With and Without Brief Motivational Interviewing in the Promotion of Human Papillomavirus Vaccination Among Chinese Men Who Have Sex With Men: Randomized Controlled Trial.
    Wang Z; Lau JTF; Ip TKM; Yu Y; Fong F; Fang Y; Mo PKH
    J Med Internet Res; 2021 Feb; 23(2):e21465. PubMed ID: 33528372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States.
    Tenner CT; Herzog K; Chaudhari S; Bini EJ; Weinshel EH
    Int J Clin Pract; 2012 Oct; 66(10):1009-13. PubMed ID: 22994334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral hepatitis vaccination in an opioid treatment program: Hartford, Connecticut, 2002-2005.
    McLaughlin P
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):48-51. PubMed ID: 17542453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
    Shapiro AJ; Esther CR; Leigh MW; Dellon EP
    Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis A and B screening and vaccination rates among patients with chronic liver disease.
    Ramirez JC; Ackerman K; Strain SC; Ahmed ST; de Los Santos MJ; Sears D
    Hum Vaccin Immunother; 2016; 12(1):64-9. PubMed ID: 26836326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial.
    Day CA; Shanahan M; Wand H; Topp L; Haber PS; Rodgers C; Deacon R; Walsh N; Kaldor J; van Beek I; Maher L;
    J Clin Virol; 2016 Jan; 74():66-72. PubMed ID: 26679830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.